Pablo Garrido‐Gil

2.4k total citations
45 papers, 1.7k citations indexed

About

Pablo Garrido‐Gil is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Pablo Garrido‐Gil has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 16 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Pablo Garrido‐Gil's work include Renin-Angiotensin System Studies (16 papers), Nuclear Receptors and Signaling (13 papers) and Receptor Mechanisms and Signaling (12 papers). Pablo Garrido‐Gil is often cited by papers focused on Renin-Angiotensin System Studies (16 papers), Nuclear Receptors and Signaling (13 papers) and Receptor Mechanisms and Signaling (12 papers). Pablo Garrido‐Gil collaborates with scholars based in Spain, United States and United Kingdom. Pablo Garrido‐Gil's co-authors include José L. Labandeira‐García, Ana I. Rodríguez‐Pérez, María J. Guerra, José L. Lanciego, Rita Valenzuela, Jannette Rodrı́guez-Pallares, Begoña Villar‐Cheda, Antonio Dominguez‐Meijide, María A. Pedrosa and Ana Borrajo and has published in prestigious journals such as Nature Communications, Brain and Brain Research.

In The Last Decade

Pablo Garrido‐Gil

43 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pablo Garrido‐Gil Spain	26	633	595	486	476	398	45	1.7k
Jannette Rodrı́guez-Pallares Spain	23	768 1.2×	809 1.4×	426 0.9×	499 1.0×	417 1.0×	49	1.8k
Chun‐Hsien Chu Taiwan	24	582 0.9×	413 0.7×	232 0.5×	182 0.4×	468 1.2×	60	1.8k
Emanuela Rasini Italy	26	445 0.7×	474 0.8×	462 1.0×	84 0.2×	577 1.4×	47	1.8k
Clotilde Lecrux Canada	17	504 0.8×	439 0.7×	249 0.5×	132 0.3×	529 1.3×	20	1.7k
Enrique Sánchez-Lemus United States	17	443 0.7×	227 0.4×	110 0.2×	496 1.0×	257 0.6×	20	1.3k
Wataru Nemoto Japan	19	349 0.6×	295 0.5×	95 0.2×	113 0.2×	174 0.4×	58	1000
Paul J. L. M. Strijbos United Kingdom	28	740 1.2×	707 1.2×	190 0.4×	79 0.2×	501 1.3×	37	2.3k
Chuansheng Zhao China	24	411 0.6×	304 0.5×	258 0.5×	47 0.1×	441 1.1×	80	1.6k
Tuomas Rauramaa Finland	20	240 0.4×	676 1.1×	476 1.0×	171 0.4×	184 0.5×	69	1.6k
F. Block Germany	30	777 1.2×	1.1k 1.9×	476 1.0×	61 0.1×	910 2.3×	99	2.6k

Countries citing papers authored by Pablo Garrido‐Gil

Since Specialization

Citations

This map shows the geographic impact of Pablo Garrido‐Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Garrido‐Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Garrido‐Gil more than expected).

Fields of papers citing papers by Pablo Garrido‐Gil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Garrido‐Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Garrido‐Gil. The network helps show where Pablo Garrido‐Gil may publish in the future.

Co-authorship network of co-authors of Pablo Garrido‐Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Garrido‐Gil. A scholar is included among the top collaborators of Pablo Garrido‐Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Garrido‐Gil. Pablo Garrido‐Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rial‐Pensado, Eva, Pablo Garrido‐Gil, Gloria Martı́nez, et al.. (2025). JNK1 in SF1 neurons regulates the central action of thyroid hormones on hepatic lipid metabolism. Molecular Metabolism. 98. 102170–102170.

Garrido‐Gil, Pablo, Rita Valenzuela, José L. Labandeira‐García, et al.. (2025). Delivery of monoclonal antibodies to the brain: the impact of nanocarrier structure. Drug Delivery and Translational Research. 16(3). 780–796.

Rodríguez‐Pérez, Ana I., Pablo Garrido‐Gil, Ana Muñoz, et al.. (2024). Non-HLA angiotensin-type-1 receptor autoantibodies mediate the long-term loss of grafted neurons in Parkinson’s disease models. Stem Cell Research & Therapy. 15(1). 138–138. 3 indexed citations

Garrido‐Gil, Pablo, et al.. (2023). Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner. Nature Communications. 14(1). 8175–8175. 15 indexed citations

Labandeira, Carmen M., María A. Pedrosa, Rita Valenzuela, et al.. (2022). Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease. npj Parkinson s Disease. 8(1). 76–76. 33 indexed citations

Milbank, Edward, Nathalia Romanelli Vicente Dragano, Pablo Garrido‐Gil, et al.. (2022). Small extracellular vesicle targeting of hypothalamic AMPKα1 promotes weight loss in leptin receptor deficient mice. Metabolism. 139. 155350–155350. 19 indexed citations

Martín‐Montañez, Elisa, David Ladrón de Guevara‐Miranda, Carmelo Millón, et al.. (2021). Insulin-like growth factor II prevents oxidative and neuronal damage in cellular and mice models of Parkinson's disease. Redox Biology. 46. 102095–102095. 22 indexed citations

López-López, Andrea, Begoña Villar‐Cheda, Pablo Garrido‐Gil, et al.. (2021). NADPH-Oxidase, Rho-Kinase and Autophagy Mediate the (Pro)renin-Induced Pro-Inflammatory Microglial Response and Enhancement of Dopaminergic Neuron Death. Antioxidants. 10(9). 1340–1340. 8 indexed citations

Rodríguez‐Pérez, Ana I., Pablo Garrido‐Gil, María A. Pedrosa, et al.. (2019). Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra. Brain Behavior and Immunity. 87. 256–271. 56 indexed citations

10.

Costa-Besada, Maria A., Rita Valenzuela, Pablo Garrido‐Gil, et al.. (2017). Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans. Molecular Neurobiology. 55(7). 5847–5867. 75 indexed citations

11.

Valenzuela, Rita, Maria A. Costa-Besada, Javier Iglesias‐González, et al.. (2016). Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration. Cell Death and Disease. 7(10). e2427–e2427. 91 indexed citations

12.

Muñoz‐Manchado, Ana B., Javier Villadiego, José A. Rodríguez‐Gómez, et al.. (2015). Chronic and progressive Parkinson's disease MPTP model in adult and aged mice. Journal of Neurochemistry. 136(2). 373–387. 68 indexed citations

13.

Muñoz, Ana, Pablo Garrido‐Gil, Antonio Dominguez‐Meijide, & José L. Labandeira‐García. (2014). Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β. Experimental Neurology. 261. 720–732. 50 indexed citations

14.

Labandeira‐García, José L., Pablo Garrido‐Gil, Jannette Rodrı́guez-Pallares, et al.. (2014). Brain renin-angiotensin system and dopaminergic cell vulnerability. Frontiers in Neuroanatomy. 8. 67–67. 97 indexed citations

15.

Dominguez‐Meijide, Antonio, et al.. (2013). Effect of chronic treatment with angiotensin type 1 receptor antagonists on striatal dopamine levels in normal rats and in a rat model of Parkinson's disease treated with l-DOPA. Neuropharmacology. 76. 156–168. 38 indexed citations

16.

Garrido‐Gil, Pablo, Belen Joglar, Ana I. Rodríguez‐Pérez, María J. Guerra, & José L. Labandeira‐García. (2012). Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease. Journal of Neuroinflammation. 9(1). 38–38. 99 indexed citations

17.

Muñoz‐Manchado, Ana B., Javier Villadiego, Pablo Garrido‐Gil, et al.. (2012). Neuroprotective and reparative effects of carotid body grafts in a chronic MPTP model of Parkinson's disease. Neurobiology of Aging. 34(3). 902–915. 25 indexed citations

18.

Labandeira‐García, José L., Jannette Rodrı́guez-Pallares, Ana I. Rodríguez‐Pérez, et al.. (2012). Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.. PubMed. 1(3). 226–44. 30 indexed citations

19.

Garrido‐Gil, Pablo, et al.. (2009). Acute and Chronic 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Administrations Elicit Similar Microglial Activation in the Substantia Nigra of Monkeys. Journal of Neuropathology & Experimental Neurology. 68(9). 977–984. 31 indexed citations

20.

Sebastián, Waldy San, et al.. (2007). Modification of the number and phenotype of striatal dopaminergic cells by carotid body graft. Brain. 130(5). 1306–1316. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact